The VMAX cohort study follows more than 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.
Methamphetamine use is a significant public health issue in Australia. It’s associated with a range of harms that increased significantly in line with:
There a few prospective studies of methamphetamine use in Australia. In 2016, we established the VMAX cohort study to determine patterns of methamphetamine use and harm in metropolitan and rural Victoria.
People in the study complete follow-up surveys once a year. They also consent to us linking administrative data obtained from health and social services to our cohort study data.
VMAX is part of a broader study called MIXMAX. This combines VMAX with SuperMIX—a study collecting data on injecting drug use over time—to form the largest active cohort study of people who use drugs in Australia.
As at November 2020, our sample looked like the following:
For more information, read: A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence
VMAX data is used to determine the nature and extent of methamphetamine use and harm in Victoria. The data has been used to determine issues related to drug driving and service provision across Victoria.
Help us understand the characteristics study participant social networks. Investigate the influence of these characteristics on drug-related risk behaviours and harms, including cessation from and relapse into drug use, and overdose.
Quantitative research including:
1
Qualitative and quantitative research, including:
2